Robert Pitti
- Immunology top 0.5%
- Immune Response and Inflammation 5
- Phagocytosis and Immune Regulation 4
- Immunotherapy and Immune Responses 3
- Cancer Research top 0.5%
- NF-κB Signaling Pathways 5
- Molecular Biology top 1%
- Cell death mechanisms and regulation 13
- Ubiquitin and proteasome pathways 3
- RNA Interference and Gene Delivery 3
- Oncology top 2%
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 5
- Co-authors
- Scot A. MarstersAvi AshkenaziChristopher J. DonahueSiegfried RuppertAudrey D. GoddardAlison MooreJames P. SheridanAustin Gurney
- Partner nations
- United StatesFrance
In The Last Decade
Robert Pitti
21 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 3.2k
- Cancer Research 1.8k
- Molecular Biology 5.3k
- Oncology 1.5k
- Immunology and Allergy 287
Countries citing papers authored by Robert Pitti
This map shows the geographic impact of Robert Pitti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pitti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pitti more than expected).
Fields of papers citing papers by Robert Pitti
This network shows the impact of papers produced by Robert Pitti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pitti. The network helps show where Robert Pitti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Pitti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 16 | |
| 2 | 2012 | 129 | |
| 3 | 2012 | 49 | |
| 4 | 2012 | 20 | |
| 5 | 2011 | 213 | |
| 6 | Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signalingbreakdown → | 2009 | 502 |
| 7 | 2008 | 120 | |
| 8 | 2007 | 487 | |
| 9 | 2000 | 328 | |
| 10 | 1999 | 152 | |
| 11 | Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancerbreakdown → | 1998 | 645 |
| 12 | 1998 | 158 | |
| 13 | A novel receptor for Apo2L/TRAIL contains a truncated death domainbreakdown → | 1997 | 557 |
| 14 | Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptorsbreakdown → | 1997 | 1474 |
| 15 | 1996 | 176 | |
| 16 | 1996 | 219 | |
| 17 | Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Familybreakdown → | 1996 | 1565 |
| 18 | 1994 | 8 | |
| 19 | 1994 | 31 | |
| 20 | 1989 | 18 |
About Robert Pitti
Robert Pitti is a scholar working on Immunology and Allergy, Immunology, Cancer Research, Molecular Biology and Oncology, having authored 21 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (13 papers), Immune Response and Inflammation (5 papers), Cell Adhesion Molecules Research (5 papers), NF-κB Signaling Pathways (5 papers), Phagocytosis and Immune Regulation (4 papers), Immunotherapy and Immune Responses (3 papers), Ubiquitin and proteasome pathways (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Immunology (3.2k citations), Cancer Research (1.8k citations), Molecular Biology (5.3k citations), Oncology (1.5k citations) and Immunology and Allergy (287 citations). Robert Pitti has collaborated with scholars based in United States and France. Frequent co-authors include Scot A. Marsters, Avi Ashkenazi, Christopher J. Donahue, Siegfried Ruppert, Audrey D. Goddard, Alison Moore, James P. Sheridan, Austin Gurney, Daryl T. Baldwin and Paul J. Godowski. Their work appears in journals such as Current Biology, Journal of Proteome Research, Cancer Cell, Proceedings of the National Academy of Sciences and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.